Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis

By Revicki Dennis   Willian Mary Kaye   Menter Alan   Gordon Kenneth   Kimball Alexa   Leonardi Craig   Langley Richard   Kimel Miriam   Okun Martin  

Journal of Dermatological Treatment, Vol. 18, Iss. 6, 2007-01 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Clinical Characterisation at Onset of Childhood Psoriasis – A Cross Sectional Study in Sweden

By Lysell Josefin   Tessma Mesfin   Nikamo Pernilla   Wahlgren Carl-Fredrik   Ståhle Mona  

Acta Dermato-Venereologica, Vol. 95, Iss. 4, 2015-04 ,pp. : 457-461

Medical Journals Limited

Access to resources Recommend Favorite

Teledermatological Monitoring of Psoriasis Patients on Biologic Therapy

By Koller Silvia   Hofmann-Wellenhof Rainer   Hayn Dieter   Weger Wolfgang   Kastner Peter   Schreier Günter   Salmhofer Wolfgang  

Acta Dermato-Venereologica, Vol. 91, Iss. 6, 2011-11 ,pp. : 680-685

Medical Journals Limited

Access to resources Recommend Favorite

Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II

By Papp Kim   Camisa Charles   Stone Stephen   Caro Ivor   Wang Xiaolin   Compton Peter   Walicke Patricia   Gottlieb Alice  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 313-323

Springer Publishing Company

Access to resources Recommend Favorite

Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England

By Khalid Javaria Mona   Fox Kathleen M   Globe Gary   Maguire Andrew   Chau Dina  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 67-72

Informa Healthcare

Access to resources Recommend Favorite